Structures by: Katsuya Y.
Total: 8
BQ123
4(C31H41N6O7Na),8(C3H8O),10(H2O)
Chemical Communications (2000) 9 743
a=25.399(5)Å b=34.717(5)Å c=25.74(3)Å
α=90.00° β=90.00° γ=90.00°
Asco6d
C72H112N16O16S4,3C3H7NO,H2O
Acta Crystallographica Section E (2001) 57, 9 o834-o838
a=11.55630(10)Å b=9.9957(2)Å c=42.9208(10)Å
α=90.00° β=91.3492(15)° γ=90.00°
Asco8-m
C38H60N8O12S4
Acta Crystallographica Section E (2001) 57, 11 o1019-o1021
a=10.7820(3)Å b=19.6026(4)Å c=22.5181(7)Å
α=90.00° β=90.00° γ=90.00°
HIV protease inhibitor KNI-272: iQoa-Mta-Apns-Thz-tBu
C33H41N5O6S2,0.803H2O
Acta Crystallographica Section C (2001) 57, 11 1333-1335
a=10.7631(4)Å b=13.1751(4)Å c=12.5623(5)Å
α=90° β=96.887(2)° γ=90°
Bq123
4(C31H41N6O7Na),8(H2O),5.63(C3H7OH)
Acta Crystallographica Section D Biological Crystallography (2001) 57, 5 628
a=25.3930(4)Å b=34.7193(3)Å c=25.7201(4)Å
α=90.00° β=90.00° γ=90.00°
Bi0.04Na0.14O2Si
Bi0.04Na0.14O2Si
Journal of the American Chemical Society (2012) 134, 2918-2921
a=24.60237(14)Å b=24.60237Å c=24.60237Å
α=90.0° β=90.0° γ=90.0°
CuGaO2
CuGaO2
Inorganic chemistry (2015) 54, 4 1698-1704
a=5.46004(1)Å b=6.61013(2)Å c=5.27417(1)Å
α=90° β=90° γ=90°
CaO3Pt
CaO3Pt
Physics and Chemistry of Minerals (2008) 35, 189-195
a=3.12607Å b=9.91983Å c=7.35059Å
α=90° β=90° γ=90°